1. 325 Immunotherapy with B cell activating antibody CPI-006 in patients (pts) with mild to moderate COVID-19 stimulates anti-SARS-CoV-2 antibody response, memory B cells and memory T effector cells. (10th December 2020) Authors: Criner, Gerard; Mobasher, Mehrdad; Hill, Craig; Hu, Shenshen; Mahabhashyam, Suresh; Brody, Joshua; Marron, Thomas; Willingham, Stephen; Miller, Richard Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A199 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 325 Immunotherapy with B cell activating antibody CPI-006 in patients (pts) with mild to moderate COVID-19 stimulates anti-SARS-CoV-2 antibody response, memory B cells and memory T effector cells. (9th November 2020) Authors: Criner, Gerard; Mobasher, Mehrdad; Hill, Craig; Hu, Shenshen; Mahabhashyam, Suresh; Brody, Joshua; Marron, Thomas; Willingham, Stephen; Miller, Richard Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A351 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Anti-CD73 antibody activates human B cells, enhances humoral responses and induces redistribution of B cells in patients with cancer. Issue 12 (5th December 2022) Authors: Miller, Richard A; Luke, Jason John; Hu, Shenshen; Mahabhashyam, Suresh; Jones, William B; Marron, Thomas; Merchan, Jaime R; Hughes, Brett G M; Willingham, Stephen B Journal: Journal for immunotherapy of cancer Issue: Volume 10:Issue 12(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗